BTF’s ASH Annual Meeting Review 2023 - Coeur d’Alene

Coeur d'Alene, ID US
March 3, 2023 to March 4, 2023

The BTF’s ASH Annual Meeting Review 2023 - Coeur d'Alene is a CME-accredited, in-person hematology conference featuring leading experts in the field. This conference allows professionals an opportunity to discuss current research and advances in the field of blood disorders and hematologic malignancies with colleagues and key opinion leaders. Expert faculty will place key abstract findings from the 64th ASH Annual Meeting into clinical context and discuss how the results may change the current standard of care. The goals of this conference are to review and critically assess practice-changing results of practice-changing clinical data and expert recommendations to optimize clinical outcomes for the patients. 

This activity is planned and implemented by the Binaytara Foundation to educate hematologists/oncologists and others involved in the care of patients with hematologic malignancies and benign hematological disorders about the most important updates from the 64th American Society of Hematology (ASH) Annual Meeting in December 2022. Neither the Binaytara Foundation nor this activity is affiliated with the American Society of Hematology (ASH). 

Target Audience

  • Hematologist/Oncologists
  • Oncology Oncology Physician Assistants/Nurse Practitioners
  • Oncology Pharmacists
  • Oncology Nurses

 

Learning Objectives

  • Review data presented at the 64th ASH Annual Meeting (2022) and discuss their application in clinical settings
  • Choose new therapeutic options for the treatment of blood disorders and hematologic malignancies, understanding appropriate indications, and contraindications to these therapeutic approaches.
  • Discuss the study design and primary endpoints of recently reported and ongoing trials that have influenced the changes in the standards of care for patients with blood disorders and hematologic malignancies.
  • Integrate evolving diagnostic, prognostic, and therapeutic approaches to the management of patients with blood disorders and hematologic malignancies.
  • Apply practical expertise gained from clinical situations emphasizing data-based approaches to patients with blood disorders and hematologic malignancies in community practice.
Course summary
Available credit: 
  • 7.50 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.50 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 7.50 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 7.50 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 7.50 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 7.50 Contact Hours.
Course opens: 
10/01/2022
Course expires: 
06/04/2023
Event starts: 
03/03/2023 - 4:00pm PST
Event ends: 
03/04/2023 - 3:35pm PST
Cost:
$300.00
Add to calendar: 

Day 1 - March 3, 2023

 

04:00 PM - 04:45 PM PST:         Registration/Networking/Exhibits

04:45 PM – 05:00 PM PST: Opening remarks

05:00 PM – 06:30 PM PST:         Session 1

Moderator: Dr. Sri Tantravahi, Dr. Prakash Vishnu, Dr. Aaron Goodman, & Dr. Sanam Loghavi   

Tumor board style case-based discussion - Dr. Arvind Chaudhry, Dr. Rangaswamy Chintapatla, Dr. Corliss Newman, Dr. Paul White, & Dr. David Aboulafia

 

Day 2 - March 4, 2023

 

07:00 AM - 08:00 AM PST:         Registration/Networking

08:00 AM - 09:30 AM PST:         Session 2

Moderator: Dr. Sri Tantravahi

08:00 AM - 08:30 AM PST:         Myelodysplastic Syndromes - Dr. Anna Halpern

08:30 AM - 09:00 AM PST:         Myeloproliferative neoplasms and CML - Dr. Sri Tantravahi

09:00 AM - 09:30 AM PST:         Acute Leukemia - Dr. Jacob Appelbaum

09:30 AM - 10:00 AM PST:         Break & exhibits

10:00 AM - 11:30 AM PST:         Session 3

Moderator: Dr. David Aboulafia

10:00 AM - 10:30 AM PST:         ITP/TTP, aHUS - Dr. George Rodgers

10:30 AM - 11:00 AM PST:         Clotting disorders & Bleeding disorders - Dr. Doris Quon

11:00 AM - 11:30 PM PST:         Panel discussion

11:30 PM - 12:30 PM PST:         Lunch & exhibits

12:30 PM - 02:00 PM PST         Session 4

Moderator: Dr. Swathi Namburi

12:30 PM - 01:00 PM PST         Chronic Lymphocytic Leukemia - Dr. Mazyar Shadman

01:00 PM - 01:30 PM PST:         Low-grade lymphomas - Dr. Harsh Shah

01:30 PM - 02:00 PM PST:         Aggressive Lymphoma - Dr. Steven Bair

02:00 PM - 02:15 PM PST:         Break & exhibits

02:15 PM - 03:45 PM PST:         Session 5

Moderator: Dr. Nathanael Gay

02:15 PM - 02:45 PM PST:         Newly diagnosed multiple myeloma - Dr. Andrew Cowan

02:45 PM - 03:15 PM PST:         Cellular therapy - Dr. Krish Patel

03:15 PM - 03:45 PM PST:         Relapsed refractory multiple myeloma - Dr. Amandeep Godara

03:45 PM - 03:50 PM PST:         Adjourn

The Coeur d'Alene Resort
115 S 2nd St
Coeur d'Alene, ID 83814
United States

A limited number of rooms have been reserved at the Coeur d'Alene Resort for participants of BTF’s ASH Annual Meeting Review 2023 - Coeur d’Alene. Please reserve your room by January 22nd, 2023 for the discounted rate listed below.

Please call (800)-688-5253 to reserve a room using our code Binaytara23, or go to https://reservations.travelclick.com/114393?groupID=3492573

parking at the venue

The Coeur d'Alene Resort provides controlled covered on-site parking. The self-parking fee is $19 per day.

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

 

Srinivas Tantravahi, MD has a financial relationship (Consulting) with Novartis; a financial relationship (Consulting) with AbbVie; a financial relationship (Research support/Grant Consultant) with Karyopharm Therapeutics.

Speaker/Topic Presenter(s)

David Aboulafia, MD

has no relevant financial relationships to disclose at this time.

Jacob Appelbaum, MD/PhD

has no relevant financial relationships to disclose at this time.

Steven Bair, MD

has a financial relationship (Independent contractor) with Acellx;.
has a financial relationship (Independent contractor) with Abbvie;.
has a financial relationship (Independent contractor) with TG Therapeutics;.

Arvind Chaudhry, MD, PhD

has no relevant financial relationships to disclose at this time.

Akhanda Chintapatla, Physician,

has no relevant financial relationships to disclose at this time.

Andrew Cowan, MD

has a financial relationship (Independent contractor) with BMS;.
has a financial relationship (Independent contractor) with Abbvie;.

Amandeep Godara, MD

has a financial relationship (Other) with Sanofi;.
has a financial relationship (Other) with Janssen;.

Anna Halpern, MD

has a financial relationship (Other) with Gilead Sciences;.
has a financial relationship (Professional Services) with Notable Labs;.
has a financial relationship (Other) with Imago Biosciences;.
has a financial relationship (Professional Services) with Abbvie;.
has a financial relationship (Other) with Jazz pharmaceuticals;.
has a financial relationship (Other) with Incytes Pharmaceuticals;.
has a financial relationship (Other) with Bayer;.
has a financial relationship (Other) with Karyopharm Therapeutics;.

Sanam Loghavi, Associate Professor

has a financial relationship (Professional Services) with Daiichi Sankyo;.
has a financial relationship (Professional Services) with Guidepoint;.
has a financial relationship (Professional Services) with Abbvie ;.
has a financial relationship (Professional Services) with OncLive;.
has a financial relationship (Stock) with Abbvie ;.
has a financial relationship (Travel) with Mission Bio ;.
has a financial relationship (Professional Services) with GLG;.
has a financial relationship (Professional Services) with Caris ;.
has a financial relationship (Professional Services) with QualWorld;.

Corliss Newman

has no relevant financial relationships to disclose at this time.

Krish Patel, MD

has a financial relationship (Professional Services) with Fate Therapeutics;.
has a financial relationship (Professional Services) with Lilly;.
has a financial relationship (Professional Services) with BeiGene;.
has a financial relationship (Professional Services) with Epizyme;.
has a financial relationship (Professional Services) with Janssen/Pharmacyclics;.
has a financial relationship (Professional Services) with Xencor;.
has a financial relationship (Professional Services) with Abbvie;.
has a financial relationship (Professional Services) with Caribou;.
has a financial relationship (Professional Services) with Kite;.
has a financial relationship (Professional Services) with ADC Therapeutics;.
has a financial relationship (Professional Services) with AstraZeneca;.
has a financial relationship (Professional Services) with BMS;.
has a financial relationship (Professional Services) with Genentech;.
has a financial relationship (Professional Services) with Pfizer;.

Doris Quon, MD, PhD

has a financial relationship (Professional Services) with NovoNordisk;.
has a financial relationship (Professional Services) with Takeda;.
has a financial relationship (Professional Services) with Sanofi;.
has a financial relationship (Professional Services) with uniQure;.
has a financial relationship (Professional Services) with Biomarin;.
has a financial relationship (Professional Services) with Octapharma;.
has a financial relationship (Professional Services) with Bayer;.
has a financial relationship (Professional Services) with Roche/Genentech;.

GEORGE RODGERS, MD, PhD

has a financial relationship (Other) with Argenx;.
has a financial relationship (Other) with Dova;.

Douglas Sborov, MD MS

has a financial relationship (Professional Services) with GlaxoSmithKline;.
has a financial relationship (Professional Services) with Janssen;.
has a financial relationship (Professional Services) with Celgene;.
has a financial relationship (Professional Services) with Sanofi;.
has a financial relationship (Professional Services) with Abbvie;.

Mazyar Shadman, MD,MPH

has a financial relationship (Professional Services) with AbbVie;.
has a financial relationship (Professional Services) with Genmab;.
has a financial relationship (Professional Services) with Mustang Bio ;.
has a financial relationship (Professional Services) with AstraZeneca;.
has a financial relationship (Professional Services) with Genentech;.
has a financial relationship (Professional Services) with BeiGene;.
has a financial relationship (Employment) with BMS;.
has a financial relationship (Professional Services) with Pharmacyclics;.
has a financial relationship (Professional Services) with TG Therapeutics;.
has a financial relationship (Professional Services) with MorphoSys/Incyte;.
has a financial relationship (Professional Services) with BMS;.

Harsh Shah, D.O.

has a financial relationship (Grant Or Contract) with BeiGene;.
has a financial relationship (Grant Or Contract) with Seattle Genetics;.

Paul White, Paul S White, MD

has no relevant financial relationships to disclose at this time.
Moderator(s)

Nathan Gay, MD

has no relevant financial relationships to disclose at this time.

Aaron Goodman, MD

has a financial relationship (Professional Services) with Seattle Genetics;.

Swathi Namburi, MD

has no relevant financial relationships to disclose at this time.

Prakash Vishnu, MD, FACP

has no relevant financial relationships to disclose at this time.

COMMERICAL SUPPORT ACKNOWLEDGMENT

This activity is supported with an independent medical education grant from Appelis Pharmaceuticals.

Available Credit

  • 7.50 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.50 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 7.50 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 7.50 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 7.50 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 7.50 Contact Hours.

 

Price

Cost:
$300.00
Please login or register to take this course.

REGISTRATION FEES 

Physicians (non-industry) - $300

Non-physician HCP (non-industry) - $200

Fellows & residents - $150

Industry representatives - $850

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is cancelled six weeks before the conference.
  • No refunds will be issued if registration is cancelled after that date.  

No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity, and completion of pre & post tests as well as course evaluations.